Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.
暂无分享,去创建一个
R. Califf | R. Giugliano | E. Braunwald | L. Newby | R. Harrington | S. Mohanavelu | C. Gibson | V. Kunadian | Yuri B. Pride | C. Zorkun | Satishkumar Mohanavelu | C. Gibson | Early Acs Investigators
[1] S. Werns. Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes , 2010 .
[2] F. Burzotta,et al. Myocardial no-reflow in humans. , 2009, Journal of the American College of Cardiology.
[3] T. Akasaka,et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. , 2009, European heart journal.
[4] I. Porto,et al. Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. , 2009, QJM : monthly journal of the Association of Physicians.
[5] Raimund Erbel,et al. Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions , 2008, Basic Research in Cardiology.
[6] J. Ottervanger,et al. Prognostic value of troponin after elective percutaneous coronary intervention: A meta‐analysis , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[7] T. Kawamoto,et al. The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation. , 2007, Journal of the American College of Cardiology.
[8] R. Kornowski,et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. , 2007, The American journal of cardiology.
[9] Stefan Neubauer,et al. Plaque Volume and Occurrence and Location of Periprocedural Myocardial Necrosis After Percutaneous Coronary Intervention: Insights From Delayed-Enhancement Magnetic Resonance Imaging, Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade Analysis, and Intravascular Ultrasound , 2006, Circulation.
[10] E. Topol,et al. Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy). , 2006, The American journal of cardiology.
[11] M. Borggrefe,et al. Side branch occlusion after coronary stent implantation in patients presenting with ST-elevation myocardial infarction: clinical impact and angiographic predictors. , 2006, American heart journal.
[12] R. Califf,et al. The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndro , 2005, American heart journal.
[13] E. Antman,et al. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. , 2004, American heart journal.
[14] G. Parodi,et al. Impact of Microvascular Dysfunction on Left Ventricular Remodeling and Long-Term Clinical Outcome After Primary Coronary Angioplasty for Acute Myocardial Infarction , 2004, Circulation.
[15] J. Ioannidis,et al. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. , 2003, Journal of the American College of Cardiology.
[16] M. Simoons,et al. Minor Myocardial Damage and Prognosis: Are Spontaneous and Percutaneous Coronary Intervention–Related Events Different? , 2002, Circulation.
[17] E. Antman,et al. Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction: A TIMI 14 Substudy , 2001, Circulation.
[18] C M Gibson,et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. , 2000, Circulation.
[19] R. Califf,et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. , 1999, European heart journal.
[20] Katherine C. Wu,et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.
[21] W. O’Neill,et al. Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. , 1997, The American journal of cardiology.
[22] E. Braunwald,et al. TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.
[23] E. Topol,et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. , 1993, Journal of the American College of Cardiology.
[24] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[25] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.